

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cAMP-mediated signaling (GO:0043951) | 9.63077435 |
| 2 | ether lipid metabolic process (GO:0046485) | 7.98685190 |
| 3 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 6.80873452 |
| 4 | regulation of acrosome reaction (GO:0060046) | 6.51310818 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.43071584 |
| 6 | regulation of protein glycosylation (GO:0060049) | 6.40599589 |
| 7 | regulation of translational termination (GO:0006449) | 5.94567667 |
| 8 | positive regulation of cAMP-mediated signaling (GO:0043950) | 5.45135382 |
| 9 | piRNA metabolic process (GO:0034587) | 5.40530353 |
| 10 | developmental pigmentation (GO:0048066) | 5.29917199 |
| 11 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.21784822 |
| 12 | sphingosine metabolic process (GO:0006670) | 5.20200928 |
| 13 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.76374348 |
| 14 | tyrosine metabolic process (GO:0006570) | 4.73453222 |
| 15 | diol metabolic process (GO:0034311) | 4.62107298 |
| 16 | opioid receptor signaling pathway (GO:0038003) | 4.54913774 |
| 17 | glycerol ether metabolic process (GO:0006662) | 4.41221142 |
| 18 | phenol-containing compound biosynthetic process (GO:0046189) | 4.36950684 |
| 19 | sphingoid metabolic process (GO:0046519) | 4.36071962 |
| 20 | regulation of protein kinase A signaling (GO:0010738) | 4.29675382 |
| 21 | ether metabolic process (GO:0018904) | 4.28124370 |
| 22 | vocalization behavior (GO:0071625) | 4.22939394 |
| 23 | cornea development in camera-type eye (GO:0061303) | 4.17988098 |
| 24 | response to histamine (GO:0034776) | 4.12169292 |
| 25 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.10798465 |
| 26 | secondary metabolic process (GO:0019748) | 4.07646824 |
| 27 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.02654368 |
| 28 | neuron recognition (GO:0008038) | 4.01982147 |
| 29 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.01795005 |
| 30 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.96340925 |
| 31 | synaptic vesicle maturation (GO:0016188) | 3.94387376 |
| 32 | regulation of cAMP-mediated signaling (GO:0043949) | 3.91717499 |
| 33 | thrombin receptor signaling pathway (GO:0070493) | 3.91199777 |
| 34 | transmission of nerve impulse (GO:0019226) | 3.84339126 |
| 35 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.84152271 |
| 36 | peptide hormone processing (GO:0016486) | 3.80856596 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 3.80490010 |
| 38 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.80490010 |
| 39 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.75791629 |
| 40 | behavioral fear response (GO:0001662) | 3.73232654 |
| 41 | behavioral defense response (GO:0002209) | 3.73232654 |
| 42 | pyrimidine dimer repair (GO:0006290) | 3.72536021 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.68335563 |
| 44 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.67400234 |
| 45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.67313231 |
| 46 | fear response (GO:0042596) | 3.66572329 |
| 47 | locomotory exploration behavior (GO:0035641) | 3.63950510 |
| 48 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.63324326 |
| 49 | positive regulation of synapse assembly (GO:0051965) | 3.61483996 |
| 50 | glycerophospholipid catabolic process (GO:0046475) | 3.59714362 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 3.58733896 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 3.54744035 |
| 53 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.54495893 |
| 54 | striatum development (GO:0021756) | 3.53289240 |
| 55 | ketone body metabolic process (GO:1902224) | 3.51236720 |
| 56 | neuron cell-cell adhesion (GO:0007158) | 3.49672174 |
| 57 | neuronal action potential (GO:0019228) | 3.48776303 |
| 58 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.46372615 |
| 59 | protein localization to synapse (GO:0035418) | 3.43445211 |
| 60 | glycosphingolipid metabolic process (GO:0006687) | 3.42078364 |
| 61 | neurotransmitter secretion (GO:0007269) | 3.41674898 |
| 62 | mating behavior (GO:0007617) | 3.40495748 |
| 63 | glutamate receptor signaling pathway (GO:0007215) | 3.35393157 |
| 64 | regulation of vesicle fusion (GO:0031338) | 3.31681537 |
| 65 | layer formation in cerebral cortex (GO:0021819) | 3.28392467 |
| 66 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.27304864 |
| 67 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.27075075 |
| 68 | negative regulation of norepinephrine secretion (GO:0010700) | 3.25729145 |
| 69 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.25630554 |
| 70 | glutamate secretion (GO:0014047) | 3.25186457 |
| 71 | regulation of memory T cell differentiation (GO:0043380) | 3.24460307 |
| 72 | neuronal action potential propagation (GO:0019227) | 3.22747238 |
| 73 | presynaptic membrane assembly (GO:0097105) | 3.21224010 |
| 74 | detection of calcium ion (GO:0005513) | 3.20901974 |
| 75 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.20758536 |
| 76 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.20758536 |
| 77 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.19129384 |
| 78 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.19129384 |
| 79 | coenzyme catabolic process (GO:0009109) | 3.18334621 |
| 80 | proline transport (GO:0015824) | 3.17985404 |
| 81 | epithelial cell fate commitment (GO:0072148) | 3.17580801 |
| 82 | neurotransmitter transport (GO:0006836) | 3.15867539 |
| 83 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.12884827 |
| 84 | dendritic spine morphogenesis (GO:0060997) | 3.12746125 |
| 85 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.11429973 |
| 86 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.11413133 |
| 87 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.10962533 |
| 88 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.10789395 |
| 89 | nodal signaling pathway (GO:0038092) | 3.09423182 |
| 90 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.09203359 |
| 91 | glomerular visceral epithelial cell development (GO:0072015) | 3.07982048 |
| 92 | membrane depolarization during action potential (GO:0086010) | 3.06447741 |
| 93 | positive regulation of gluconeogenesis (GO:0045722) | 3.05760962 |
| 94 | cellular response to ammonium ion (GO:0071242) | 3.05451539 |
| 95 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.04971462 |
| 96 | presynaptic membrane organization (GO:0097090) | 3.04404066 |
| 97 | cellular response to alkaloid (GO:0071312) | 3.01328375 |
| 98 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.00117692 |
| 99 | respiratory electron transport chain (GO:0022904) | 2.99813461 |
| 100 | behavioral response to ethanol (GO:0048149) | 2.99588148 |
| 101 | regulation of postsynaptic membrane potential (GO:0060078) | 2.97875323 |
| 102 | electron transport chain (GO:0022900) | 2.97172999 |
| 103 | activation of protein kinase A activity (GO:0034199) | 2.96613399 |
| 104 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.94756785 |
| 105 | glycolipid metabolic process (GO:0006664) | 2.94210156 |
| 106 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.93322114 |
| 107 | epithelial cilium movement (GO:0003351) | 2.92557856 |
| 108 | regulation of female receptivity (GO:0045924) | 2.91156352 |
| 109 | calcium ion import (GO:0070509) | 2.91031407 |
| 110 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.90806289 |
| 111 | regulation of neurotransmitter uptake (GO:0051580) | 2.89944921 |
| 112 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.89093056 |
| 113 | signal peptide processing (GO:0006465) | 2.88929005 |
| 114 | thyroid hormone metabolic process (GO:0042403) | 2.88538218 |
| 115 | negative regulation of adenylate cyclase activity (GO:0007194) | 2.88384896 |
| 116 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.87976259 |
| 117 | membrane depolarization (GO:0051899) | 2.86449242 |
| 118 | suckling behavior (GO:0001967) | 2.86302871 |
| 119 | neuronal ion channel clustering (GO:0045161) | 2.86229233 |
| 120 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.86078355 |
| 121 | short-term memory (GO:0007614) | 2.85611480 |
| 122 | notochord development (GO:0030903) | 2.85570898 |
| 123 | axonal fasciculation (GO:0007413) | 2.84892248 |
| 124 | mRNA cleavage (GO:0006379) | 2.84703054 |
| 125 | regulation of neurotransmitter levels (GO:0001505) | 2.84601071 |
| 126 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.83785791 |
| 127 | regulation of appetite (GO:0032098) | 2.83210833 |
| 128 | signal complex assembly (GO:0007172) | 2.83027809 |
| 129 | * adult feeding behavior (GO:0008343) | 2.82849759 |
| 130 | negative regulation of lyase activity (GO:0051350) | 2.82736802 |
| 131 | ncRNA catabolic process (GO:0034661) | 2.82552852 |
| 132 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.82308319 |
| 133 | dopamine transport (GO:0015872) | 2.81585870 |
| 134 | glycosphingolipid biosynthetic process (GO:0006688) | 2.81559526 |
| 135 | neuron-neuron synaptic transmission (GO:0007270) | 2.81033328 |
| 136 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.80726934 |
| 137 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.80195791 |
| 138 | heart field specification (GO:0003128) | 2.79022268 |
| 139 | secondary heart field specification (GO:0003139) | 2.79022268 |
| 140 | membrane lipid metabolic process (GO:0006643) | 2.78723078 |
| 141 | exploration behavior (GO:0035640) | 2.78205264 |
| 142 | pigment biosynthetic process (GO:0046148) | 2.77693906 |
| 143 | adaptation of signaling pathway (GO:0023058) | 2.77368047 |
| 144 | transferrin transport (GO:0033572) | 2.76438542 |
| 145 | vesicle transport along microtubule (GO:0047496) | 2.75199557 |
| 146 | regulation of synapse assembly (GO:0051963) | 2.74318707 |
| 147 | negative regulation of cyclase activity (GO:0031280) | 2.72862307 |
| 148 | thyroid hormone generation (GO:0006590) | 2.72757000 |
| 149 | fat-soluble vitamin catabolic process (GO:0042363) | 2.72310667 |
| 150 | vitamin catabolic process (GO:0009111) | 2.72310667 |
| 151 | neuromuscular process controlling posture (GO:0050884) | 2.71842173 |
| 152 | regulation of translational elongation (GO:0006448) | 2.71714591 |
| 153 | retinal rod cell development (GO:0046548) | 2.70630747 |
| 154 | peptidyl-arginine N-methylation (GO:0035246) | 2.70125735 |
| 155 | peptidyl-arginine methylation (GO:0018216) | 2.70125735 |
| 156 | angiotensin maturation (GO:0002003) | 2.69485905 |
| 157 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.69247571 |
| 158 | L-glutamate transport (GO:0015813) | 2.67919471 |
| 159 | synaptic transmission, glutamatergic (GO:0035249) | 2.67845504 |
| 160 | glomerular epithelial cell development (GO:0072310) | 2.66349102 |
| 161 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.66106863 |
| 162 | liposaccharide metabolic process (GO:1903509) | 2.65432772 |
| 163 | negative regulation of exocytosis (GO:0045920) | 2.64955147 |
| 164 | dendrite development (GO:0016358) | 2.64937907 |
| 165 | acidic amino acid transport (GO:0015800) | 2.63353744 |
| 166 | protein K11-linked deubiquitination (GO:0035871) | 2.61709628 |
| 167 | glycine transport (GO:0015816) | 2.59360788 |
| 168 | regulation of feeding behavior (GO:0060259) | 2.59296616 |
| 169 | ferric iron transport (GO:0015682) | 2.58899503 |
| 170 | trivalent inorganic cation transport (GO:0072512) | 2.58899503 |
| 171 | innervation (GO:0060384) | 2.57969092 |
| 172 | positive regulation of protein complex disassembly (GO:0043243) | 2.55697593 |
| 173 | GPI anchor metabolic process (GO:0006505) | 2.53678712 |
| 174 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.52331521 |
| 175 | sphingolipid metabolic process (GO:0006665) | 2.51262458 |
| 176 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.51049619 |
| 177 | cardiac right ventricle morphogenesis (GO:0003215) | 2.50752238 |
| 178 | positive regulation of fatty acid transport (GO:2000193) | 2.49402275 |
| 179 | polyol biosynthetic process (GO:0046173) | 2.48240334 |
| 180 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.46789914 |
| 181 | regulation of cardioblast proliferation (GO:0003264) | 2.46789914 |
| 182 | response to dietary excess (GO:0002021) | 2.46285672 |
| 183 | left/right axis specification (GO:0070986) | 2.45357809 |
| 184 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.45150719 |
| 185 | melanin biosynthetic process (GO:0042438) | 12.8649159 |
| 186 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 12.0608092 |
| 187 | melanin metabolic process (GO:0006582) | 11.5664662 |
| 188 | secondary metabolite biosynthetic process (GO:0044550) | 10.5492737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.17234906 |
| 2 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10808037 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04799819 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.01572810 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90381106 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.89864188 |
| 7 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.77044320 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71372784 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67037187 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67037187 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53640954 |
| 12 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.52064541 |
| 13 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.51292649 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45842208 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40673009 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40468390 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39946418 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.39109116 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.36771491 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.35281444 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31668917 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.29925338 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.26065629 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.22617118 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.12469059 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10853790 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09264980 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.06597974 |
| 29 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.05160234 |
| 30 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.05160234 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01504097 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97458877 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97394785 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.96659070 |
| 35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.84553997 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.83312661 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79311786 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.77910600 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77173022 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72409506 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.71921458 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.70711957 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67035055 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65421437 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.64271285 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61955830 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61352516 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59124885 |
| 49 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.59003103 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58168550 |
| 51 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.58045803 |
| 52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.58045803 |
| 53 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.56827218 |
| 54 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.55591208 |
| 55 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.55591208 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50232479 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49718631 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.49670829 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49163431 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45093925 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43801472 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41309892 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40189352 |
| 64 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.37102303 |
| 65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36878773 |
| 66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36555708 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35943267 |
| 68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32513541 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31695623 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30978712 |
| 71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30962631 |
| 72 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.30469343 |
| 73 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.29934940 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28624456 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28190817 |
| 76 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26538510 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26227932 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26087314 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.26075262 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.25678873 |
| 81 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25315531 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23943673 |
| 83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22058218 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18398744 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17956527 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17587727 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.17499941 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17424525 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16264370 |
| 90 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14434284 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10968532 |
| 92 | JUN_21703547_ChIP-Seq_K562_Human | 1.10831511 |
| 93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10303593 |
| 94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10303593 |
| 95 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10149112 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09577401 |
| 97 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09564479 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09309444 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09212451 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08856653 |
| 101 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08476888 |
| 102 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07668170 |
| 103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07236361 |
| 104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07228414 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06889152 |
| 106 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05292333 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04896448 |
| 108 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03875779 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02865970 |
| 110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02847406 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02765876 |
| 112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02715537 |
| 113 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00688021 |
| 114 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00629894 |
| 115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00549547 |
| 116 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.98259685 |
| 117 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98027110 |
| 118 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96921053 |
| 119 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.96433106 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96036810 |
| 121 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95958317 |
| 122 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95902401 |
| 123 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95810420 |
| 124 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.95708359 |
| 125 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95606570 |
| 126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95203982 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94721935 |
| 128 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94430376 |
| 129 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94084755 |
| 130 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.93966795 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93634819 |
| 132 | AR_19668381_ChIP-Seq_PC3_Human | 0.93628050 |
| 133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93589326 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93142942 |
| 135 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92509577 |
| 136 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91901651 |
| 137 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91557811 |
| 138 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91186163 |
| 139 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91113016 |
| 140 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90841470 |
| 141 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90801481 |
| 142 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.90344728 |
| 143 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90061965 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89444045 |
| 145 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87884405 |
| 146 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87475456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 6.47388774 |
| 2 | MP0000372_irregular_coat_pigmentation | 5.64959524 |
| 3 | MP0005171_absent_coat_pigmentation | 5.64136886 |
| 4 | MP0009278_abnormal_bone_marrow | 3.90948985 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.61051921 |
| 6 | MP0003122_maternal_imprinting | 3.45821833 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.42872947 |
| 8 | MP0003136_yellow_coat_color | 3.42362573 |
| 9 | MP0003880_abnormal_central_pattern | 3.36909985 |
| 10 | MP0005645_abnormal_hypothalamus_physiol | 3.15012589 |
| 11 | MP0005408_hypopigmentation | 3.10804580 |
| 12 | MP0003941_abnormal_skin_development | 2.96274376 |
| 13 | MP0009745_abnormal_behavioral_response | 2.81012903 |
| 14 | MP0009046_muscle_twitch | 2.74164382 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.72880946 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.55454781 |
| 17 | MP0002064_seizures | 2.52186460 |
| 18 | MP0004381_abnormal_hair_follicle | 2.49863502 |
| 19 | MP0002736_abnormal_nociception_after | 2.45686445 |
| 20 | MP0005646_abnormal_pituitary_gland | 2.39772203 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.39195162 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.35892699 |
| 23 | MP0003879_abnormal_hair_cell | 2.28612306 |
| 24 | MP0005360_urolithiasis | 2.19157781 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 2.17204165 |
| 26 | MP0001545_abnormal_hematopoietic_system | 2.17204165 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 2.06429822 |
| 28 | MP0002063_abnormal_learning/memory/cond | 2.03231866 |
| 29 | MP0005367_renal/urinary_system_phenotyp | 2.02774292 |
| 30 | MP0000516_abnormal_urinary_system | 2.02774292 |
| 31 | MP0003195_calcinosis | 1.94111663 |
| 32 | MP0000371_diluted_coat_color | 1.93367393 |
| 33 | MP0005503_abnormal_tendon_morphology | 1.90919867 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.86686667 |
| 35 | MP0002102_abnormal_ear_morphology | 1.82846956 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.78998487 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.77911363 |
| 38 | MP0001984_abnormal_olfaction | 1.77829355 |
| 39 | MP0001905_abnormal_dopamine_level | 1.72696594 |
| 40 | MP0004885_abnormal_endolymph | 1.71268948 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.70835457 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.69006364 |
| 43 | MP0001486_abnormal_startle_reflex | 1.67183077 |
| 44 | MP0000681_abnormal_thyroid_gland | 1.64042988 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.61994286 |
| 46 | MP0009764_decreased_sensitivity_to | 1.61883698 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.61494556 |
| 48 | MP0002693_abnormal_pancreas_physiology | 1.58044693 |
| 49 | MP0002272_abnormal_nervous_system | 1.57891622 |
| 50 | MP0001944_abnormal_pancreas_morphology | 1.56691870 |
| 51 | MP0003121_genomic_imprinting | 1.55081749 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.55078142 |
| 53 | MP0002095_abnormal_skin_pigmentation | 1.53900858 |
| 54 | MP0001664_abnormal_digestion | 1.52486854 |
| 55 | MP0005379_endocrine/exocrine_gland_phen | 1.47289241 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.46907999 |
| 57 | MP0001324_abnormal_eye_pigmentation | 1.45832107 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.45316665 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.43743521 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.41979238 |
| 61 | MP0003878_abnormal_ear_physiology | 1.41979238 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 1.38297163 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.36648285 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 1.29043724 |
| 65 | MP0004043_abnormal_pH_regulation | 1.28606458 |
| 66 | MP0004924_abnormal_behavior | 1.25265770 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.25265770 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.25091118 |
| 69 | MP0004142_abnormal_muscle_tone | 1.24780648 |
| 70 | MP0001270_distended_abdomen | 1.21243451 |
| 71 | MP0001756_abnormal_urination | 1.20931050 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.19411959 |
| 73 | MP0005257_abnormal_intraocular_pressure | 1.18221411 |
| 74 | MP0005253_abnormal_eye_physiology | 1.17280540 |
| 75 | MP0003690_abnormal_glial_cell | 1.14752405 |
| 76 | MP0002184_abnormal_innervation | 1.13359822 |
| 77 | MP0002090_abnormal_vision | 1.12749089 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.09826805 |
| 79 | MP0001970_abnormal_pain_threshold | 1.09375782 |
| 80 | MP0004270_analgesia | 1.07540790 |
| 81 | MP0003329_amyloid_beta_deposits | 1.07463341 |
| 82 | MP0005332_abnormal_amino_acid | 1.04710184 |
| 83 | MP0010329_abnormal_lipoprotein_level | 1.04606652 |
| 84 | MP0003123_paternal_imprinting | 1.04132460 |
| 85 | MP0001529_abnormal_vocalization | 1.02548254 |
| 86 | MP0000747_muscle_weakness | 1.01832200 |
| 87 | MP0010678_abnormal_skin_adnexa | 1.00346352 |
| 88 | MP0000427_abnormal_hair_cycle | 0.98726435 |
| 89 | MP0002075_abnormal_coat/hair_pigmentati | 0.95756137 |
| 90 | MP0000751_myopathy | 0.95497934 |
| 91 | MP0002163_abnormal_gland_morphology | 0.92937268 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.92845852 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 0.92520602 |
| 94 | MP0008569_lethality_at_weaning | 0.92460957 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.92298312 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 0.91984578 |
| 97 | MP0005220_abnormal_exocrine_pancreas | 0.90825207 |
| 98 | MP0003959_abnormal_lean_body | 0.90802011 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.90657792 |
| 100 | MP0005499_abnormal_olfactory_system | 0.87051896 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.87051896 |
| 102 | MP0002909_abnormal_adrenal_gland | 0.86822464 |
| 103 | MP0002733_abnormal_thermal_nociception | 0.85991541 |
| 104 | MP0000778_abnormal_nervous_system | 0.85722247 |
| 105 | MP0002882_abnormal_neuron_morphology | 0.85088418 |
| 106 | MP0002254_reproductive_system_inflammat | 0.84192717 |
| 107 | * MP0002078_abnormal_glucose_homeostasis | 0.82833674 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.82089349 |
| 109 | MP0008995_early_reproductive_senescence | 0.81939302 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.81389604 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.81285496 |
| 112 | MP0005623_abnormal_meninges_morphology | 0.79900040 |
| 113 | MP0003646_muscle_fatigue | 0.78811979 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.78128486 |
| 115 | MP0004883_abnormal_blood_vessel | 0.77269650 |
| 116 | MP0005164_abnormal_response_to | 0.76044080 |
| 117 | MP0005409_darkened_coat_color | 0.75824209 |
| 118 | MP0003011_delayed_dark_adaptation | 0.75375504 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.74788116 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.74725099 |
| 121 | MP0005448_abnormal_energy_balance | 0.73570360 |
| 122 | MP0008872_abnormal_physiological_respon | 0.73512097 |
| 123 | MP0005389_reproductive_system_phenotype | 0.72880228 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.72197056 |
| 125 | MP0001919_abnormal_reproductive_system | 0.71767798 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.71690343 |
| 127 | MP0002837_dystrophic_cardiac_calcinosis | 0.71395000 |
| 128 | * MP0002069_abnormal_eating/drinking_beha | 0.71261035 |
| 129 | MP0003633_abnormal_nervous_system | 0.69775377 |
| 130 | MP0003632_abnormal_nervous_system | 0.68658471 |
| 131 | MP0002229_neurodegeneration | 0.68076585 |
| 132 | MP0001963_abnormal_hearing_physiology | 0.67978588 |
| 133 | MP0004085_abnormal_heartbeat | 0.67554422 |
| 134 | MP0003950_abnormal_plasma_membrane | 0.67548069 |
| 135 | MP0005195_abnormal_posterior_eye | 0.67180260 |
| 136 | MP0001186_pigmentation_phenotype | 0.66988529 |
| 137 | MP0004742_abnormal_vestibular_system | 0.66672987 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.66428489 |
| 139 | MP0000003_abnormal_adipose_tissue | 0.66330772 |
| 140 | MP0003634_abnormal_glial_cell | 0.66295528 |
| 141 | MP0009333_abnormal_splenocyte_physiolog | 0.65892917 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.65801158 |
| 143 | MP0003631_nervous_system_phenotype | 0.65619455 |
| 144 | MP0005670_abnormal_white_adipose | 0.65163621 |
| 145 | MP0002752_abnormal_somatic_nervous | 0.65095411 |
| 146 | MP0006036_abnormal_mitochondrial_physio | 0.64821300 |
| 147 | MP0010771_integument_phenotype | 0.62900228 |
| 148 | MP0003045_fibrosis | 0.61825855 |
| 149 | MP0003787_abnormal_imprinting | 0.60573284 |
| 150 | MP0002877_abnormal_melanocyte_morpholog | 0.59933007 |
| 151 | MP0005075_abnormal_melanosome_morpholog | 0.59930222 |
| 152 | MP0006072_abnormal_retinal_apoptosis | 0.59428675 |
| 153 | MP0006138_congestive_heart_failure | 0.58377401 |
| 154 | MP0004811_abnormal_neuron_physiology | 0.58307706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Blue irides (HP:0000635) | 7.06992185 |
| 2 | Intestinal atresia (HP:0011100) | 6.88918264 |
| 3 | Focal motor seizures (HP:0011153) | 5.88793673 |
| 4 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 5.16339548 |
| 5 | Large for gestational age (HP:0001520) | 5.08553352 |
| 6 | Aplasia/Hypoplasia of the macula (HP:0008059) | 5.06915443 |
| 7 | Volvulus (HP:0002580) | 4.99565658 |
| 8 | Iris hypopigmentation (HP:0007730) | 4.98131913 |
| 9 | Ocular albinism (HP:0001107) | 4.68961429 |
| 10 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.61593812 |
| 11 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.52319923 |
| 12 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.49231250 |
| 13 | Hypoplasia of the fovea (HP:0007750) | 4.49231250 |
| 14 | Abnormality of the aortic arch (HP:0012303) | 4.39141811 |
| 15 | Generalized hypopigmentation (HP:0007513) | 4.27142566 |
| 16 | Broad alveolar ridges (HP:0000187) | 4.27054276 |
| 17 | Gastrointestinal atresia (HP:0002589) | 3.97958624 |
| 18 | Focal seizures (HP:0007359) | 3.91708298 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.87229908 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.74390580 |
| 21 | Congenital sensorineural hearing impairment (HP:0008527) | 3.74368878 |
| 22 | Thickened helices (HP:0000391) | 3.70566938 |
| 23 | Visual hallucinations (HP:0002367) | 3.70177154 |
| 24 | Poor head control (HP:0002421) | 3.63113336 |
| 25 | Polyphagia (HP:0002591) | 3.57818132 |
| 26 | Abnormality of the fovea (HP:0000493) | 3.52331868 |
| 27 | Febrile seizures (HP:0002373) | 3.51223809 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.44952431 |
| 29 | Mesangial abnormality (HP:0001966) | 3.42206462 |
| 30 | Atonic seizures (HP:0010819) | 3.32002044 |
| 31 | Absence seizures (HP:0002121) | 3.23745332 |
| 32 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.18136037 |
| 33 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.18136037 |
| 34 | Cerebellar dysplasia (HP:0007033) | 3.15480505 |
| 35 | Hyperthyroidism (HP:0000836) | 3.11832122 |
| 36 | Large eyes (HP:0001090) | 3.10564452 |
| 37 | Tubular atrophy (HP:0000092) | 3.03014182 |
| 38 | Oligodontia (HP:0000677) | 2.98939328 |
| 39 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.97701975 |
| 40 | White forelock (HP:0002211) | 2.96030470 |
| 41 | Pheochromocytoma (HP:0002666) | 2.95294518 |
| 42 | Cutaneous melanoma (HP:0012056) | 2.93634079 |
| 43 | Lissencephaly (HP:0001339) | 2.93590786 |
| 44 | Myokymia (HP:0002411) | 2.92495724 |
| 45 | Hypopigmentation of the fundus (HP:0007894) | 2.86908535 |
| 46 | Abnormal ciliary motility (HP:0012262) | 2.86497781 |
| 47 | Dialeptic seizures (HP:0011146) | 2.83391597 |
| 48 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.82776288 |
| 49 | Hypothermia (HP:0002045) | 2.79845016 |
| 50 | Pancreatic fibrosis (HP:0100732) | 2.78566672 |
| 51 | Generalized hypopigmentation of hair (HP:0011358) | 2.75382503 |
| 52 | Agitation (HP:0000713) | 2.67152707 |
| 53 | Hypoplasia of the iris (HP:0007676) | 2.65248040 |
| 54 | Progressive cerebellar ataxia (HP:0002073) | 2.65221478 |
| 55 | Oligomenorrhea (HP:0000876) | 2.63559081 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.59097163 |
| 57 | Retinal dysplasia (HP:0007973) | 2.59089403 |
| 58 | Pendular nystagmus (HP:0012043) | 2.57370980 |
| 59 | Absent/shortened dynein arms (HP:0200106) | 2.56724601 |
| 60 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.56724601 |
| 61 | Abnormality of the axillary hair (HP:0100134) | 2.56033738 |
| 62 | Abnormality of secondary sexual hair (HP:0009888) | 2.56033738 |
| 63 | Abnormality of the corticospinal tract (HP:0002492) | 2.52496064 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.51484724 |
| 65 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.51484724 |
| 66 | Calf muscle hypertrophy (HP:0008981) | 2.50638331 |
| 67 | Attenuation of retinal blood vessels (HP:0007843) | 2.50377988 |
| 68 | Scanning speech (HP:0002168) | 2.50201474 |
| 69 | Patchy hypopigmentation of hair (HP:0011365) | 2.49450792 |
| 70 | Epileptic encephalopathy (HP:0200134) | 2.49032668 |
| 71 | Hyperpituitarism (HP:0010514) | 2.48656924 |
| 72 | Goiter (HP:0000853) | 2.47518486 |
| 73 | Ketoacidosis (HP:0001993) | 2.44945444 |
| 74 | Neuroendocrine neoplasm (HP:0100634) | 2.43299987 |
| 75 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.43006193 |
| 76 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.43006193 |
| 77 | Progressive inability to walk (HP:0002505) | 2.42122053 |
| 78 | Hypoventilation (HP:0002791) | 2.41603100 |
| 79 | Episodic fever (HP:0001954) | 2.41284985 |
| 80 | Subacute progressive viral hepatitis (HP:0006572) | 2.39584268 |
| 81 | Abnormality of the vitreous humor (HP:0004327) | 2.38191345 |
| 82 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.38040801 |
| 83 | Pancreatic cysts (HP:0001737) | 2.37257365 |
| 84 | Anxiety (HP:0000739) | 2.36433905 |
| 85 | Intention tremor (HP:0002080) | 2.34793007 |
| 86 | Gait imbalance (HP:0002141) | 2.32531519 |
| 87 | Amelogenesis imperfecta (HP:0000705) | 2.31163254 |
| 88 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.29844424 |
| 89 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.27053186 |
| 90 | Truncal ataxia (HP:0002078) | 2.26942672 |
| 91 | Molar tooth sign on MRI (HP:0002419) | 2.24437044 |
| 92 | Abnormality of midbrain morphology (HP:0002418) | 2.24437044 |
| 93 | Optic nerve hypoplasia (HP:0000609) | 2.23379841 |
| 94 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.19184839 |
| 95 | Ankle clonus (HP:0011448) | 2.15564656 |
| 96 | Testicular neoplasm (HP:0010788) | 2.14721888 |
| 97 | Broad-based gait (HP:0002136) | 2.14384011 |
| 98 | Abnormality of the ileum (HP:0001549) | 2.14349006 |
| 99 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.13574187 |
| 100 | Tented upper lip vermilion (HP:0010804) | 2.13023762 |
| 101 | Hypoplasia of the pons (HP:0012110) | 2.11867151 |
| 102 | Hypercortisolism (HP:0001578) | 2.11741159 |
| 103 | Narrow nasal bridge (HP:0000446) | 2.11524707 |
| 104 | Hepatocellular necrosis (HP:0001404) | 2.11284898 |
| 105 | Spinal cord compression (HP:0002176) | 2.11096169 |
| 106 | Esotropia (HP:0000565) | 2.08109411 |
| 107 | Hypoproteinemia (HP:0003075) | 2.08106918 |
| 108 | Peripheral hypomyelination (HP:0007182) | 2.08085928 |
| 109 | Abnormality of the pons (HP:0007361) | 2.07518350 |
| 110 | Poor speech (HP:0002465) | 2.06731186 |
| 111 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.06085491 |
| 112 | Heterochromia iridis (HP:0001100) | 2.05696707 |
| 113 | Spastic tetraplegia (HP:0002510) | 2.05304053 |
| 114 | Psychosis (HP:0000709) | 2.04707894 |
| 115 | Abnormal drinking behavior (HP:0030082) | 2.02862801 |
| 116 | Polydipsia (HP:0001959) | 2.02862801 |
| 117 | Depression (HP:0000716) | 2.02712298 |
| 118 | Poor suck (HP:0002033) | 2.02568794 |
| 119 | 3-Methylglutaconic aciduria (HP:0003535) | 2.01714692 |
| 120 | Supranuclear gaze palsy (HP:0000605) | 2.00429089 |
| 121 | Conjunctival hamartoma (HP:0100780) | 2.00335660 |
| 122 | Severe visual impairment (HP:0001141) | 2.00321342 |
| 123 | Thyroid-stimulating hormone excess (HP:0002925) | 10.7632954 |
| 124 | Neurofibrillary tangles (HP:0002185) | 1.99379439 |
| 125 | Congenital primary aphakia (HP:0007707) | 1.98449802 |
| 126 | Dysmetria (HP:0001310) | 1.97242592 |
| 127 | Abnormality of macular pigmentation (HP:0008002) | 1.95933787 |
| 128 | Severe muscular hypotonia (HP:0006829) | 1.94769299 |
| 129 | Drooling (HP:0002307) | 1.94273991 |
| 130 | Excessive salivation (HP:0003781) | 1.94273991 |
| 131 | Restlessness (HP:0000711) | 1.94190460 |
| 132 | Vascular calcification (HP:0004934) | 1.92934147 |
| 133 | Ankyloglossia (HP:0010296) | 1.92758857 |
| 134 | Abnormal hair laboratory examination (HP:0003328) | 1.92632084 |
| 135 | Tachypnea (HP:0002789) | 1.92308849 |
| 136 | Mitochondrial inheritance (HP:0001427) | 1.91766121 |
| 137 | Pachygyria (HP:0001302) | 1.89805421 |
| 138 | Amblyopia (HP:0000646) | 1.89354641 |
| 139 | Nephrogenic diabetes insipidus (HP:0009806) | 1.88838165 |
| 140 | Abnormal gallbladder physiology (HP:0012438) | 1.88763244 |
| 141 | Cholecystitis (HP:0001082) | 1.88763244 |
| 142 | Increased corneal curvature (HP:0100692) | 1.88364066 |
| 143 | Keratoconus (HP:0000563) | 1.88364066 |
| 144 | Failure to thrive in infancy (HP:0001531) | 1.86881929 |
| 145 | Limb dystonia (HP:0002451) | 1.86318832 |
| 146 | Tubulointerstitial nephritis (HP:0001970) | 1.85702772 |
| 147 | Hamartoma of the eye (HP:0010568) | 1.84966232 |
| 148 | Acute necrotizing encephalopathy (HP:0006965) | 1.84200883 |
| 149 | Progressive macrocephaly (HP:0004481) | 1.83921329 |
| 150 | Rhinitis (HP:0012384) | 1.83462453 |
| 151 | Abnormality of the labia minora (HP:0012880) | 1.83440355 |
| 152 | Medial flaring of the eyebrow (HP:0010747) | 1.83407229 |
| 153 | Hemiparesis (HP:0001269) | 1.83101264 |
| 154 | Hypophosphatemic rickets (HP:0004912) | 1.83099891 |
| 155 | Metaphyseal dysplasia (HP:0100255) | 1.81009756 |
| 156 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.80576932 |
| 157 | Hypohidrosis (HP:0000966) | 1.80524865 |
| 158 | Hypoalbuminemia (HP:0003073) | 1.79869181 |
| 159 | Abnormal albumin level (HP:0012116) | 1.79869181 |
| 160 | Cerebral inclusion bodies (HP:0100314) | 1.79715951 |
| 161 | Sleep apnea (HP:0010535) | 1.79157520 |
| 162 | Entropion (HP:0000621) | 1.78895898 |
| 163 | Myositis (HP:0100614) | 1.78671281 |
| 164 | Akinesia (HP:0002304) | 1.78030037 |
| 165 | Specific learning disability (HP:0001328) | 1.77735008 |
| 166 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.76555057 |
| 167 | Exotropia (HP:0000577) | 1.76535409 |
| 168 | Cerebral hemorrhage (HP:0001342) | 1.75758380 |
| 169 | Dysdiadochokinesis (HP:0002075) | 1.74740555 |
| 170 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.74690854 |
| 171 | Methylmalonic aciduria (HP:0012120) | 1.73894279 |
| 172 | Type II lissencephaly (HP:0007260) | 1.73849849 |
| 173 | Hydroxyprolinuria (HP:0003080) | 1.73112775 |
| 174 | Abnormality of proline metabolism (HP:0010907) | 1.73112775 |
| 175 | True hermaphroditism (HP:0010459) | 1.72564961 |
| 176 | Abnormality of the alveolar ridges (HP:0006477) | 1.72519092 |
| 177 | Ketosis (HP:0001946) | 1.71933539 |
| 178 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.70876312 |
| 179 | Hyperventilation (HP:0002883) | 1.70638104 |
| 180 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69908414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.24993879 |
| 2 | GRK7 | 4.41571758 |
| 3 | TNIK | 3.76472319 |
| 4 | NTRK3 | 3.45818418 |
| 5 | PINK1 | 3.23692076 |
| 6 | MAP3K9 | 2.99334094 |
| 7 | MAP3K12 | 2.87285856 |
| 8 | FGFR2 | 2.73941347 |
| 9 | CASK | 2.73429461 |
| 10 | PIM2 | 2.54899524 |
| 11 | MAP3K4 | 2.46459018 |
| 12 | ACVR1B | 2.36409041 |
| 13 | MAP3K13 | 2.34527719 |
| 14 | MAP2K7 | 2.33853287 |
| 15 | MAP2K4 | 2.21971698 |
| 16 | ERN1 | 2.10867990 |
| 17 | FER | 1.96411737 |
| 18 | MET | 1.95681577 |
| 19 | MARK1 | 1.74701803 |
| 20 | NTRK2 | 1.74674591 |
| 21 | WNK3 | 1.71832109 |
| 22 | GRK1 | 1.70090723 |
| 23 | EPHA3 | 1.68145509 |
| 24 | BMPR1B | 1.50173885 |
| 25 | AKT3 | 1.49160494 |
| 26 | BMX | 1.43769869 |
| 27 | MINK1 | 1.43240736 |
| 28 | ADRBK1 | 1.38191560 |
| 29 | TAOK3 | 1.38169140 |
| 30 | TNK2 | 1.34443269 |
| 31 | STK24 | 1.31857887 |
| 32 | UHMK1 | 1.30562882 |
| 33 | FRK | 1.29726888 |
| 34 | MST4 | 1.20203267 |
| 35 | FES | 1.19334584 |
| 36 | PAK3 | 1.18323377 |
| 37 | CAMKK2 | 1.12483134 |
| 38 | NME1 | 1.11590598 |
| 39 | MAPK11 | 1.09984828 |
| 40 | PKN2 | 1.09618423 |
| 41 | TAOK1 | 1.07037617 |
| 42 | NTRK1 | 1.06237085 |
| 43 | ARAF | 1.03812631 |
| 44 | LATS2 | 1.03372892 |
| 45 | KSR2 | 1.02964044 |
| 46 | TGFBR1 | 1.01401655 |
| 47 | MAPK13 | 1.00885908 |
| 48 | CAMK2A | 0.99135765 |
| 49 | FGFR3 | 0.97875463 |
| 50 | SCYL2 | 0.92437846 |
| 51 | CDK5 | 0.89760286 |
| 52 | PRKD3 | 0.86363274 |
| 53 | PRKCH | 0.85176408 |
| 54 | STK39 | 0.81638683 |
| 55 | SIK2 | 0.80317104 |
| 56 | DYRK3 | 0.80165433 |
| 57 | ADRBK2 | 0.79415485 |
| 58 | PRKCI | 0.79359172 |
| 59 | IRAK1 | 0.77537984 |
| 60 | MAP3K1 | 0.77411825 |
| 61 | PRKCE | 0.76979860 |
| 62 | CDK19 | 0.76066405 |
| 63 | STK38L | 0.75956842 |
| 64 | MAP4K2 | 0.74589092 |
| 65 | STK3 | 0.73115723 |
| 66 | PNCK | 0.72255503 |
| 67 | MAP2K6 | 0.71684913 |
| 68 | RET | 0.67614837 |
| 69 | DDR2 | 0.67044444 |
| 70 | MAPK15 | 0.66722539 |
| 71 | ALK | 0.64288328 |
| 72 | BRSK2 | 0.62076678 |
| 73 | CAMK2B | 0.60668636 |
| 74 | MAP3K6 | 0.60664446 |
| 75 | DYRK1B | 0.58834125 |
| 76 | OXSR1 | 0.57197745 |
| 77 | CAMKK1 | 0.57164754 |
| 78 | PTK2B | 0.56666760 |
| 79 | ERBB2 | 0.55261301 |
| 80 | DAPK2 | 0.55058847 |
| 81 | MOS | 0.54945452 |
| 82 | PLK2 | 0.54146788 |
| 83 | PHKG1 | 0.53691012 |
| 84 | PHKG2 | 0.53691012 |
| 85 | PIK3CG | 0.53208029 |
| 86 | PAK6 | 0.52934165 |
| 87 | INSRR | 0.52309432 |
| 88 | KSR1 | 0.52299805 |
| 89 | MYLK | 0.51646257 |
| 90 | FLT3 | 0.51455076 |
| 91 | HIPK2 | 0.50864088 |
| 92 | CAMK1 | 0.50088451 |
| 93 | CSNK1G2 | 0.48734205 |
| 94 | CSNK1G3 | 0.47157294 |
| 95 | WNK4 | 0.46739941 |
| 96 | GSK3A | 0.45706267 |
| 97 | MARK3 | 0.45687032 |
| 98 | CSNK1A1L | 0.45676700 |
| 99 | CAMK1G | 0.44694732 |
| 100 | PRKCG | 0.43821952 |
| 101 | MARK2 | 0.42664619 |
| 102 | FGR | 0.42441618 |
| 103 | SGK1 | 0.41851663 |
| 104 | STK38 | 0.41206676 |
| 105 | PRKG2 | 0.40483844 |
| 106 | PRKCQ | 0.39408642 |
| 107 | CAMK2D | 0.38672487 |
| 108 | PRKACA | 0.38265473 |
| 109 | IRAK3 | 0.38161894 |
| 110 | CDC42BPA | 0.38064041 |
| 111 | ABL2 | 0.37791268 |
| 112 | EPHA4 | 0.37609134 |
| 113 | STK11 | 0.37427413 |
| 114 | PRKD2 | 0.36011311 |
| 115 | PRKCA | 0.33942216 |
| 116 | MAP3K5 | 0.33385324 |
| 117 | MAPK12 | 0.33343259 |
| 118 | PRKAA2 | 0.33076624 |
| 119 | ABL1 | 0.32308227 |
| 120 | PRKG1 | 0.32213579 |
| 121 | CSNK1D | 0.30987272 |
| 122 | RPS6KA3 | 0.30135676 |
| 123 | AKT2 | 0.30055399 |
| 124 | CSNK1A1 | 0.30038033 |
| 125 | EIF2AK3 | 0.29985739 |
| 126 | WEE1 | 0.29906795 |
| 127 | PRKACG | 0.29033810 |
| 128 | CSNK1G1 | 0.28523088 |
| 129 | ROCK1 | 0.28323050 |
| 130 | MAP2K1 | 0.27646389 |
| 131 | LMTK2 | 0.27587181 |
| 132 | ZAK | 0.27097591 |
| 133 | CAMK1D | 0.27090874 |
| 134 | SGK223 | 0.26701852 |
| 135 | SGK494 | 0.26701852 |
| 136 | TYRO3 | 0.26477557 |
| 137 | CSNK1E | 0.26180415 |
| 138 | PRKCB | 0.25870434 |
| 139 | ERBB3 | 0.25862240 |
| 140 | DAPK3 | 0.25789406 |
| 141 | PRKAA1 | 0.24723958 |
| 142 | BRSK1 | 0.24412013 |
| 143 | DYRK1A | 0.24298558 |
| 144 | PRKCZ | 0.24129349 |
| 145 | TRPM7 | 0.23100072 |
| 146 | BCR | 0.21011411 |
| 147 | LIMK1 | 0.20473530 |
| 148 | RIPK1 | 0.18692686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.53749197 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.15813227 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.10499399 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.08636763 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.07934332 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.96441746 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.78434621 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.73762955 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.58994681 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.22690284 |
| 11 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.11461998 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.11084305 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.10417142 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.06334148 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.06139972 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.99762349 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.99109362 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.96081489 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95302189 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.95257214 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.93977691 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.88838831 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.87543389 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.80848137 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.79166298 |
| 26 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.78640867 |
| 27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.67485221 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67479388 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.65924241 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64310208 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.61179261 |
| 32 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60927627 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.58693574 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56673406 |
| 35 | Melanogenesis_Homo sapiens_hsa04916 | 1.52128771 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51000173 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.48005608 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.46488845 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.40406255 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39744336 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.38419025 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.37773493 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.37307723 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.35064721 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28139313 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.26515284 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.26432911 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21653556 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.19370930 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.16985281 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16626807 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15449785 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13619818 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05623191 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04384635 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03052526 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02364947 |
| 58 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.02284853 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01828816 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 1.00411874 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97776689 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97422332 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96914776 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96672835 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95736353 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94373048 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.94158169 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93930656 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93906400 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93281349 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93053748 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91722565 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91354260 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91016288 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89333419 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87160683 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.84415584 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83346875 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81183716 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80458814 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80395261 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.80225477 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78223548 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76790585 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75875455 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.75438285 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.75391767 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75355410 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71653001 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69995096 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69241661 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69047689 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68909575 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.68635690 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68588970 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67717440 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65436608 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63430195 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63186725 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63135862 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.60839147 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.60661289 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60544750 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59271000 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55219916 |
| 106 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54410214 |
| 107 | Peroxisome_Homo sapiens_hsa04146 | 0.52875333 |
| 108 | Protein export_Homo sapiens_hsa03060 | 0.52836800 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51421968 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51312328 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50713257 |
| 112 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.50198176 |
| 113 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50161194 |
| 114 | Alcoholism_Homo sapiens_hsa05034 | 0.49979356 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49788467 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49559170 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.48817662 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48117103 |
| 119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47848064 |
| 120 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47121629 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46306026 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46052092 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45447205 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45013815 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43353554 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42812705 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.41800407 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41618710 |
| 129 | Melanoma_Homo sapiens_hsa05218 | 0.41364699 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41194237 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41013706 |
| 132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40842241 |
| 133 | Phagosome_Homo sapiens_hsa04145 | 0.39176347 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39047117 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38715547 |
| 136 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36073982 |
| 137 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36051765 |
| 138 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35492740 |
| 139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33608854 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33594018 |
| 141 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33062461 |
| 142 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29415076 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28668553 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27997448 |
| 145 | ABC transporters_Homo sapiens_hsa02010 | 0.26859095 |
| 146 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26146075 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25100838 |
| 148 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24737409 |
| 149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23866497 |
| 150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23773020 |
| 151 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23195675 |

